Unemployment transitions and self-rated health in Europe: A longitudinal analysis of EU-SILC from 2008 to 2011

Tøge, Anne Grete; Blekesaune, Morten

doi:10.1016/j.socscimed.2015.08.040

Cited by 71 publications

(68 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Bene ciaries were mainly adults, with functional disability and a low level of education, unemployed, and with one or more children. There is wide evidence regarding the relationships between level of education, as a measure of socioeconomic position, and health [21], and unemployment and health [22]. The proportion of divorced people was higher than in the general population, which could indicate lower social support for PB bene ciaries, compared with the rest of the population [23,24].…”

Section: Discussionmentioning

confidence: 99%

Who suffers from pharmaceutical poverty and what are their needs? Evidence from a Spanish region.

Rubio-Valera¹,

Marqués-Ercilla

Peñarrubia-María

et al. 2020

Preprint

View full text Add to dashboard Cite

Background Pharmaceutical poverty occurs when a patient cannot afford the cost of prescribed medication and/or medical products. Non-profit organisations are covering the cost of medication to those patients in some contexts. The aim of the study was to describe the population of beneficiaries of the PB, a non-governmental organization which provides free of charge access to medicines, and their utilization pattern of medicines and healthcare products. Methods This was an observational study using PB beneficiary data collected between November 2017 and December 2018 in Catalonia. The Catalan Health Service provided information from the general population. A descriptive analysis of the beneficiaries’ characteristics was conducted and compared to general population. Results The beneficiaries (N = 1206) were mainly adults with a low level of education, unemployed, with functional disability and with ≥ 1 children. Compared with the general population, the beneficiaries were older, had a lower level of education, showed a higher prevalence of functional disability, were less likely to be Spanish, and more likely to be divorced and unemployed. The beneficiaries were polymedicated and most were using medication related to the nervous (79%), musculo-skeletal (68%) and cardiovascular system (56%) and alimentary tract and metabolism (68%). Almost 19% of beneficiaries used healthcare products. Female beneficiaries were older and more likely to be divorced or widowed, employed and with children. Compared to men, women were more likely to use medicines for pain and mental disorders. The paediatric group used medications for severe, chronic conditions (heart diseases, autoimmune diseases, conduct disorders and attention deficit hyperactivity disorder). Conclusions Patients with severe, chronic and disabling conditions are affected by pharmaceutical poverty. While the system of co-payment remains unchanged, physicians and paediatricians should explore economic barriers to treatment and direct their patients to resources that help to cover the cost of treatment.

show abstract

Section: Discussionmentioning

confidence: 99%

Who suffers from pharmaceutical poverty and what are their needs? Evidence from a Spanish region.

Rubio-Valera¹,

Marqués-Ercilla

Peñarrubia-María

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…In order to account for time-constant unobserved heterogeneity, possibly correlated with the employment condition, a fixed-effects approach based on information on the transitions of the variables of interest can be adopted, so as to avoid parametric assumptions [5,41]. Unfortunately, the lack of time variation in our variables of interest does not allow us to pursue this kind of strategy.…”

Section: Discussionmentioning

confidence: 99%

“…Consequences range from poorer Self-evaluated Health Status (SHS henceforth) [5,6], mental illness [7,8], higher incidence of cardio-vascular diseases [9] and all-cause mortality [10]. In addition, long-term unemployment exacerbates the negative health effects of unemployment [11] and is associated with a higher incidence of suicide [12].…”

Section: Introductionmentioning

confidence: 99%

Employment Condition, Economic Deprivation and Self-Evaluated Health in Europe: Evidence from EU-SILC 2009–2012

Bacci¹,

Pigini²,

Seracini³

et al. 2017

IJERPH

View full text Add to dashboard Cite

Background: The mixed empirical evidence about employment conditions (i.e., permanent vs. temporary job, full-time vs. part-time job) as well as unemployment has motivated the development of conceptual models with the aim of assessing the pathways leading to effects of employment status on health. Alongside physically and psychologically riskier working conditions, one channel stems in the possibly severe economic deprivation faced by temporary workers. We investigate whether economic deprivation is able to partly capture the effect of employment status on Self-evaluated Health Status (SHS). Methods: Our analysis is based on the European Union Statistics on Income and Living Conditions (EU-SILC) survey, for a balanced sample from 26 countries from 2009 to 2012. We estimate a correlated random-effects logit model for the SHS that accounts for the ordered nature of the dependent variable and the longitudinal structure of the data. Results and Discussion: Material deprivation and economic strain are able to partly account for the negative effects on SHS from precarious and part-time employment as well as from unemployment that, however, exhibits a significant independent negative association with SHS. Conclusions: Some of the indicators used to proxy economic deprivation are significant predictors of SHS and their correlation with the employment condition is such that it should not be neglected in empirical analysis, when available and further to the monetary income.

show abstract

“…Table 5 Discussion Bene ciaries were mainly adults, with functional disability and a low level of education, unemployed, and with one or more children. There is wide evidence regarding the relationships between level of education, as a measure of socioeconomic position, and health [21], and unemployment and health [22]. The proportion of divorced people was higher than in the general population, which could indicate lower social support for PB bene ciaries, compared with the rest of the population [23,24].…”

Section: Na: Not Availablementioning

confidence: 99%

Who suffers from pharmaceutical poverty and what are their needs? Evidence from a Spanish region.

Rubio-Valera¹,

Marqués-Ercilla

Peñarrubia-María

et al. 2020

Preprint

View full text Add to dashboard Cite

Background Pharmaceutical poverty occurs when a patient cannot afford the cost of prescribed medication and/or medical products. Non-profit organisations are covering the cost of medication to those patients in some contexts. The aim of the study was to describe the population of beneficiaries of the PB, a non-governmental organization based on Primary Healthcare system, which provides free of charge access to medicines, and their utilization pattern of medicines and healthcare products. Methods This was an observational study using PB beneficiary data collected between November 2017 and December 2018 in Catalonia. The Catalan Health Service provided information from the general population. A descriptive analysis of the beneficiaries’ characteristics was conducted and compared to general population. Results The beneficiaries (N = 1206) were mainly adults with a low level of education, unemployed, with functional disability and with ≥ 1 children. Compared with the general population, the beneficiaries were older, had a lower level of education, showed a higher prevalence of functional disability, were less likely to be Spanish, and more likely to be divorced and unemployed. The beneficiaries were polymedicated and most were using medication related to the nervous (79%), musculo-skeletal (68%) and cardiovascular system (56%) and alimentary tract and metabolism (68%). Almost 19% of beneficiaries used healthcare products. Female beneficiaries were older and more likely to be divorced or widowed, employed and with children. Compared to men, women were more likely to use medicines for pain and mental disorders. The paediatric group used medications for severe, chronic conditions (heart diseases, autoimmune diseases, conduct disorders and attention deficit hyperactivity disorder). Conclusions Patients with severe, chronic and disabling conditions are affected by pharmaceutical poverty. While the system of co-payment remains unchanged, family physicians and paediatricians should explore economic barriers to treatment and direct their patients to resources that help to cover the cost of treatment.

show abstract

Unemployment transitions and self-rated health in Europe: A longitudinal analysis of EU-SILC from 2008 to 2011

Cited by 71 publications

References 42 publications

Who suffers from pharmaceutical poverty and what are their needs? Evidence from a Spanish region.

Who suffers from pharmaceutical poverty and what are their needs? Evidence from a Spanish region.

Employment Condition, Economic Deprivation and Self-Evaluated Health in Europe: Evidence from EU-SILC 2009–2012

Who suffers from pharmaceutical poverty and what are their needs? Evidence from a Spanish region.

Contact Info

Product

Resources

About